Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Gilead gets another HIV treatment approval, extending lenacapavir's dominance

Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 27 August →